Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00162305
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2005-09-09
Brief Title:
A Phase IIA Study of BMS-512148 to Assess Safety Exposure and Biological Effects in Stable Type 2 Diabetic Subjects
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Double-blind Placebo-controlled Randomized Multiple-dose Study to Evaluate the Safety Pharmacokinetics and Pharmacodynamics of Bms-512148 in Diabetic Subjects
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical research study is to assess the safety of exposure to and biological effects of BMS-512148 in stable Type 2 diabetic subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None